The 11th Edition of the European Pharmacopoeia (EP) main volume and supplements are legally binding and details the qualitative and quantitative composition of medicines, the Tests to be carried out on medicines, on the raw materials used in the production of medicines and on the intermediates of synthesis.
The EP is a single reference work for the quality control of medicines in Europe. All producers of medicines or substances for pharmaceutical use must apply the quality standards of the European Pharmacopoeia for the marketing and use of these products in Europe.
The EP outlines preparations for pharmaceutical use of chemical, animal, human or herbal origin. It also covers biological, blood and plasma derivatives, vaccines and radiopharmaceutical preparations. The monographs give quality standards for all the main medicines used in Europe.
The 11th Edition consists of all the texts published in the 10th Edition, which may subsequently have been revised or corrected, and new texts. The new edition now includes QR codes for easier linking to the Knowledge database and contains a Subscription Key (EPID Code) giving access to the EP’s online archives.
Publication Schedule |
Published |
Implemented |
EP Supplement 11.3 |
July 2023 |
January 2024 |
EP Supplement 11.4 |
October 2023 |
April 2024 |
EP Supplement 11.2 |
January 2024 |
July 2024 |
The EP is a subscription product and all orders must be prepaid. Renouf's price includes the shipping costs to deliver the three supplements.